Immunomedics Inc (NASDAQ:IMMU)

14.99
Delayed Data
As of 4:00pm ET
 +0.52 / +3.59%
Today’s Change
11.55
Today|||52-Week Range
27.33
+5.05%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close14.47
Today’s open14.50
Day’s range14.43 - 15.00
Volume1,340,385
Average volume (3 months)2,609,827
Market cap$2.8B
Data as of 4:00pm ET, 07/17/2019

Growth & Valuation

Earnings growth (last year)-13.77%
Earnings growth (this year)+8.55%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book10.47

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.09-0.16%
NEOGNeogen Corp+0.64+1.00%
--Quidel Corp-1.00-1.96%
MYGNMyriad Genetics Inc+0.31+1.19%
Data as of 4:00pm ET, 07/17/2019

Financials

Next reporting dateAugust 28, 2019
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$0.00
Annual profit (last year)-$157.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Financial &
Business Officer
Usama Malik
Chief Technology Officer
Morris Z. Rosenberg
Corporate headquarters
Morris Plains, New Jersey

Forecasts